Sodium alterations in isolated rat heart during cardioplegic arrest

Schepkin, V. D., I. O. Choy, and T. F. Budinger. Sodiumalterations in isolated rat heart during cardioplegic arrest. J. Appl. Physiol. 81(6):2696-2702, 1996.Triple-quantum-filtered (TQF) Na nuclearmagnetic resonance (NMR) without chemical shift reagent is used toinvestigate Na derangement in isolated crystalloid perfused rat heartsduring St. Thomas cardioplegic (CP) arrest. Theextracellular Na contribution to the NMR TQF signal of a rat heart isfound to be 73 ± 5%, as determined by wash-out experiments atdifferent moments of ischemia and reperfusion. With the use of thiscontribution factor, the estimated intracellular Na([Na⁺]_i)TQF signal is 222 ± 13% of preischemic level after 40 min of CParrest and 30 min of reperfusion, and the heart rate pressure productrecovery is 71 ± 8%. These parameters aresignificantly better than for stop-flow ischemia: 340 ± 20% and 6 ± 3%, respectively. At 37°C, the initial delay of 15 min in[Na⁺]_igrowth occurs during CP arrest along with reduced growth later (~4.0%/min) in comparison with stop-flow ischemia (~6.7%/min). The hypothermia (21°C, 40 min) for the stop-flow ischemia and CPdramatically decreases the[Na⁺]_igain with the highest heart recovery for CP (~100%). These studiesconfirm the enhanced sensitivity of TQF NMR to[Na⁺]_iand demonstrate the potential of NMR without chemical shift reagent tomonitor[Na⁺]_iderangements.

     

2D NMR of the Metabolic Antioxidant Dihydrolipoic Acid and its Derivatives

Dihydroplipoate and lipoate are physiological thiols which in addition to their coenzyme functions exhibit antioxidant activity. For NMR investigations of their protective mechanism in biological and model systems it is very important to know the full assignment of proton and carbon spectra of these molecules in water (D₂O). An unambiguous assignment of proton and carbon NMR spectra has been made for dihydrolipoate and its short chain derivatives bisnor-and tetranor-lipoic acid in D₂O and CDCl₃ solutions using 2D NMR methods.

Oxidation of dihydrolipoic acid produces substantial electron density deshielding of the carbons nearest to the SH groups with the largest shift found at the inner SH group (17.79 ppm in D₂O, 16.93 in CDCl₃) and almost no changes in the tail portion of the molecule. However, bisnor-dihydrolipoic acid and especially tetranor-dihydrolipoic acid have more carbon deshielding near the outer SH group of the molecule which correlates with their known diminished ion chelating activity.

Moreover, the proton triplet at position 2 of lipoic acid has strong pH dependence (pK = 4.58) due to the close proximity to the carboxylic group and this feature may be used for monitoring pH.     

A conjugate of a tumor-targeting ligand and a T cell costimulatory antibody to treat brain tumors

T cell immunotherapy is a potential strategy for the treatment of brain tumors because it offers a high degree of specificity, the ability to extravasate into solid tumors, and the potential for eliciting a long-term protective immune response. Various approaches have been developed to overcome T cell immune tolerance to cancer, including the use of cytokines and bispecific antibodies. T cell stimulation with the proinflammatory cytokine IL-12 can elicit antitumor immunity. T cell activation can be increased using bispecific antibodies against activating molecules on the surface of T cells and a tumor antigen. We studied the effects of systemic IL-12 administration in combination with a conjugate of an anti-CD28 antibody and a ligand for the folate receptor. The high affinity folate receptor is expressed on endogenously arising choroid plexus tumors of SV11 mice, which are transgenic for large T antigen under the control of the SV40 promoter. SV11 mice are immunocompetent, yet immunologically tolerant to large T antigen expressed by choroid plexus tumors. MRI analysis showed that the administration of IL-12 and anti-CD28 Fab/folate significantly slowed tumor growth. Proliferating CD8(+) T cells were found in choroid plexus tumors of treated animals. Treatment of animals with IL-12 + anti-CD28 Fab/folate prolonged survival compared to IL-12 alone. Cytokine treatment combined with tumor-targeted costimulation may be a useful adjunct treatment.